Halozyme Therapeutics (NASDAQ:HALO) is preparing to release its quarterly earnings on Tuesday, 2026-02-17. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Halozyme Therapeutics to report an earnings per share (EPS) of $2.15.
The announcement from Halozyme Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
The company’s EPS beat by $0.14 in the last quarter, leading to a 2.79% increase in the share price on the following day.
Here’s …